Sign inJoin Free
DashboardSign out
Free Lesson Preview
Module 1: Lesson 1
Managing participant visits and ongoing engagement
How clinical research professionals manage study visits, support participant adherence, handle protocol deviations, facilitate adverse event reporting, and maintain effective participant relationships throughout the trial.
What you will learn
By the end of this lesson, you will be able to:
Managing the study visit schedule
Every clinical trial follows a protocol that specifies exactly what must happen and when. As a clinical research professional, your role is to translate this protocol into a practical schedule that participants can follow while maintaining the scientific integrity the study requires.
Understanding visit timing requirements
Visit schedules are designed to capture data at scientifically meaningful timepoints. When you schedule participants, you need to understand why specific timing matters. If a study examines how a medication affects inflammation over time, the protocol requires laboratory tests at weeks 2, 4, 8, and 12 to track inflammatory marker changes. If researchers want to know how quickly a drug works, assessments might be scheduled at days 1, 3, 7, and 14.
The protocol also reflects the medication's pharmacology. Some drugs require close monitoring early in treatment when side effects are most likely, then less frequently once tolerability is established. Other drugs require ongoing surveillance because effects are cumulative or delayed. Understanding these rationales helps you explain to participants why their visit schedule matters and motivates adherence.
In a typical year-long rheumatoid arthritis trial, the protocol might require visits at enrollment, then at weeks 4, 8, 12, 24, 36, and 52. Each visit has specific assessments tied to it. Your job is to ensure participants understand this schedule, have it documented clearly, and receive reminders that keep them on track.
Working with visit windows
Protocols define visit windows—acceptable ranges around target dates when visits can still occur. A Week 8 visit might have a window of plus or minus three days, meaning the participant can come any time from Day 53 through Day 59 and remain within protocol.
Visit windows are not unlimited flexibility. They represent the maximum acceptable deviation before data becomes unusable or participant safety might be compromised. When scheduling participants, aim for target dates whenever possible; use windows as backup rather than default.
Document your scheduling rationale. If you consistently schedule participants at the edge of windows, you may face questions during monitoring visits. If a participant must be scheduled outside the window, document the reason and discuss with the investigator whether the visit should proceed and how to handle the protocol deviation.
Good Clinical Practice (GCP)
Full course · Clinical Research Foundations